HHS launches plan to limit ‘overprescribing’ of psychiatric drugs

Key Points:

• US Health and Human Services Secretary Robert F. Kennedy Jr. announced a plan to reduce overprescribing of psychiatric medications, promote alternative treatments, and support medication discontinuation when appropriate, emphasizing patient autonomy and informed consent.
• The initiative aims to shift mental health care toward prevention, transparency, and holistic approaches, including family support, dietary changes, therapy, and physical activity, with coordinated efforts across HHS agencies.
• Psychiatry experts generally welcome the focus on improving psychiatric care but caution that overemphasis on overprescribing risks overshadowing ongoing issues like inadequate access to mental health services and workforce shortages.
• Critics highlight that many individuals with serious mental health conditions lack adequate care, with only about 40% of those with depression receiving therapy and concerns about rising suicide rates, urging balanced attention to both overprescribing and underprescribing.
• Medical professionals stress the importance of careful clinical assessment, avoiding stigma, and involving physicians in any medication changes, warning against patients discontinuing psychiatric drugs without medical supervision.